UNITED THERAPEUTICS Corp (UTHR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 300M 600M 900M Q3 '16: 408.2M Q4 '16: 409M Q1 '17: 370.5M Q2 '17: 444.6M Q3 '17: 445.5M Q4 '17: 464.7M Q1 '18: 389.2M Q2 '18: 444.5M Q3 '18: 412.7M Q4 '18: 381.4M Q1 '19: 362.6M Q2 '19: 373.6M Q3 '19: 401.5M Q4 '19: 311.1M Q1 '20: 356.3M Q2 '20: 362M Q3 '20: 380.1M Q4 '20: 384.9M Q1 '21: 379.1M Q2 '21: 446.5M Q3 '21: 444.7M Q4 '21: 415.2M Q1 '22: 461.9M Q2 '22: 466.9M Q3 '22: 516M Q4 '22: 491.5M Q1 '23: 506.9M Q2 '23: 596.5M Q3 '23: 609.4M Q4 '23: 614.7M Q1 '24: 677.7M Q2 '24: 714.9M Q3 '24: 748.9M Q4 '24: 735.9M Q1 '25: 794.4M Q2 '25: 798.6M Q3 '25: 799.5M Q4 '25: 790.2M Q1 '26: 781.5M Q2 '26: 783.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 250M 500M 750M Q3 '15: 379.3M Q4 '15: 379.6M Q1 '16: 368.3M Q2 '16: 392.6M Q3 '16: 384.6M Q4 '16: 380.6M Q1 '17: 356.2M Q2 '17: 425.7M Q3 '17: 426M Q4 '17: 411.7M Q1 '18: 336M Q2 '18: 382.8M Q3 '18: 360.8M Q4 '18: 349.5M Q1 '19: 333.5M Q2 '19: 346.9M Q3 '19: 368.5M Q4 '19: 282.3M Q1 '21: 356.1M Q2 '21: 409.3M Q3 '21: 417M Q4 '21: 380.6M Q1 '22: 436M Q2 '22: 437.2M Q3 '22: 478.8M Q4 '22: 432.7M Q1 '23: 454.6M Q2 '23: 532.4M Q3 '23: 539.3M Q4 '23: 543.7M Q1 '24: 604.8M Q2 '24: 637.1M Q3 '24: 665.8M Q4 '24: 660M Q1 '25: 701.9M Q2 '25: 711M Q3 '25: 698.6M Q4 '25: 686.8M Q1 '26: 648.1M Q2 '26: 683.8M Q3 '16 Q4 '17 Q1 '19 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-750M -500M -250M 0 250M 500M 750M Q3 '16: 238.6M Q4 '16: 174.2M Q1 '17: 263.6M Q2 '17: 88.5M Q3 '17: 323.8M Q4 '17: 139M Q1 '18: 306.9M Q2 '18: 217.4M Q3 '18: 149.6M Q4 '18: 131.5M Q1 '19: -655.9M Q2 '19: 221.4M Q3 '19: 183.4M Q4 '19: 63.5M Q1 '20: 166.7M Q2 '20: 140.5M Q3 '20: 221.1M Q4 '20: 65.3M Q1 '21: -64.8M Q2 '21: 222.2M Q3 '21: 228.7M Q4 '21: 169.8M Q1 '22: 288M Q2 '22: 201.8M Q3 '22: 314.3M Q4 '22: 175.6M Q1 '23: 284.4M Q2 '23: 313.4M Q3 '23: 327M Q4 '23: 260.1M Q1 '24: 356.3M Q2 '24: 319.9M Q3 '24: 343.1M Q4 '24: 357.7M Q1 '25: 382.8M Q2 '25: 364.5M Q3 '25: 388.5M Q4 '25: 356.7M Q1 '26: 325.8M Q2 '26: 330.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-600M -400M -200M 0 200M 400M 600M Q3 '16: 161.8M Q4 '16: 110.3M Q1 '17: 178.6M Q2 '17: -56M Q3 '17: 276.3M Q4 '17: 19M Q1 '18: 244.5M Q2 '18: 172.9M Q3 '18: 106.5M Q4 '18: 65.3M Q1 '19: -494.6M Q2 '19: 205.1M Q3 '19: 132.4M Q4 '19: 52.6M Q1 '20: 137.7M Q2 '20: 107.1M Q3 '20: 171.2M Q4 '20: 98.8M Q1 '21: 28.3M Q2 '21: 172.6M Q3 '21: 162.7M Q4 '21: 112.2M Q1 '22: 239.9M Q2 '22: 116M Q3 '22: 239.3M Q4 '22: 132.1M Q1 '23: 240.9M Q2 '23: 259.2M Q3 '23: 267.6M Q4 '23: 217.1M Q1 '24: 306.6M Q2 '24: 278.1M Q3 '24: 309.1M Q4 '24: 301.3M Q1 '25: 322.2M Q2 '25: 309.5M Q3 '25: 338.7M Q4 '25: 364.3M Q1 '26: 274.9M Q2 '26: 333M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 50M 100M 150M Q1 '17: 14.3M Q2 '17: 18.9M Q3 '17: 19.5M Q4 '17: 53M Q1 '18: 53.2M Q2 '18: 61.7M Q3 '18: 51.9M Q4 '18: 31.9M Q1 '19: 29.1M Q2 '19: 26.7M Q3 '19: 33M Q4 '19: 28.8M Q1 '20: 23.4M Q2 '20: 25.9M Q3 '20: 24M Q4 '20: 34.8M Q1 '21: 23M Q2 '21: 37.2M Q3 '21: 27.7M Q4 '21: 34.6M Q1 '22: 25.9M Q2 '22: 29.7M Q3 '22: 37.2M Q4 '22: 58.8M Q1 '23: 52.3M Q2 '23: 64.1M Q3 '23: 70.1M Q4 '23: 71M Q1 '24: 72.9M Q2 '24: 77.8M Q3 '24: 83.1M Q4 '24: 75.9M Q1 '25: 92.5M Q2 '25: 87.6M Q3 '25: 100.9M Q4 '25: 103.4M Q1 '26: 133.4M Q2 '26: 99.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-750M -500M -250M 0 250M 500M 750M Q2 '16: 125.7M Q3 '16: 228.7M Q4 '16: 163.4M Q1 '17: 230.8M Q2 '17: 70.7M Q3 '17: 258.5M Q1 '18: 275.7M Q2 '18: 179.8M Q3 '18: 237.5M Q4 '18: 85.4M Q1 '19: -627.4M Q2 '19: 132.9M Q3 '19: 185.4M Q4 '19: 102.5M Q1 '20: 214.6M Q2 '20: 164M Q3 '20: 250.9M Q4 '20: 126.2M Q1 '21: 89.8M Q2 '21: 148.2M Q3 '21: 185.6M Q4 '21: 174.6M Q1 '22: 288.7M Q2 '22: 127M Q3 '22: 258.6M Q4 '22: 128.2M Q1 '23: 374.8M Q2 '23: 106.3M Q3 '23: 346.2M Q4 '23: 150.7M Q1 '24: 376.5M Q2 '24: 232.2M Q3 '24: 377.2M Q4 '24: 341.2M Q1 '25: 461.2M Q2 '25: 191.7M Q3 '25: 562.1M Q4 '25: 346.2M Q1 '26: 463.3M Q2 '26: 313.6M Q2 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-750M -500M -250M 0 250M 500M 750M Q2 '16: 115.3M Q3 '16: 219.6M Q4 '16: 148.7M Q1 '17: 215.2M Q2 '17: 49.8M Q3 '17: 236.5M Q1 '18: 238.1M Q2 '18: 126.3M Q3 '18: 196M Q4 '18: 33.6M Q1 '19: -652.5M Q2 '19: 112.6M Q3 '19: 171.8M Q4 '19: 77.8M Q1 '20: 201.6M Q2 '20: 145.8M Q3 '20: 235.1M Q4 '20: 113.9M Q1 '21: 79.2M Q2 '21: 131.9M Q3 '21: 162.3M Q4 '21: 104M Q1 '22: 275.2M Q2 '22: 110M Q3 '22: 189.8M Q4 '22: 88.7M Q1 '23: 333.5M Q2 '23: 61.6M Q3 '23: 280.5M Q4 '23: 72M Q1 '24: 338.3M Q2 '24: 187.1M Q3 '24: 300.7M Q4 '24: 254.5M Q1 '25: 386.3M Q2 '25: 129.5M Q3 '25: 351.6M Q4 '25: 173.3M Q1 '26: 362.5M Q2 '26: 205.6M Q2 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '13: 52.6M Q3 '13: 53.7M Q1 '14: 56.7M Q2 '14: 53.3M Q3 '14: 47.3M Q1 '15: 46.7M Q2 '15: 51.9M Q3 '15: 50.2M Q1 '16: 48.7M Q2 '16: 46.9M Q3 '16: 46.2M Q1 '17: 45.9M Q2 '17: 44.9M Q3 '17: 44.1M Q1 '18: 43.9M Q2 '18: 43.4M Q3 '18: 44M Q1 '19: 43.7M Q2 '19: 44M Q3 '19: 44M Q1 '20: 44.1M Q2 '20: 44.4M Q3 '20: 44.6M Q1 '21: 46.4M Q2 '21: 47.3M Q3 '21: 47.6M Q1 '22: 47.7M Q2 '22: 48.1M Q3 '22: 48.7M Q1 '23: 49.6M Q2 '23: 49.5M Q3 '23: 49.7M Q1 '24: 49.7M Q2 '24: 47.5M Q3 '24: 48.4M Q1 '25: 48.6M Q2 '25: 48.3M Q3 '25: 47.3M Q1 '26: 47.2M Q2 '26: 45.8M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.00 0.00 10.00 20.00 30.00 Q3 '16: 14.83 Q4 '16: 15.16 Q1 '17: 14.21 Q2 '17: 8.57 Q3 '17: 11.34 Q4 '17: 9.34 Q1 '18: 11.02 Q2 '18: 16.25 Q3 '18: 12.40 Q4 '18: 13.45 Q1 '19: -3.44 Q2 '19: -2.76 Q3 '19: -2.17 Q4 '19: -2.45 Q1 '20: 11.99 Q2 '20: 9.74 Q3 '20: 10.57 Q4 '20: 11.54 Q1 '21: 9.03 Q2 '21: 10.27 Q3 '21: 9.85 Q4 '21: 10.02 Q1 '22: 14.44 Q2 '22: 13.20 Q3 '22: 14.69 Q4 '22: 15.00 Q1 '23: 14.83 Q2 '23: 17.66 Q3 '23: 18.13 Q4 '23: 19.81 Q1 '24: 21.12 Q2 '24: 21.73 Q3 '24: 22.74 Q4 '24: 24.62 Q1 '25: 25.08 Q2 '25: 25.64 Q3 '25: 26.41 Q4 '25: 27.89 Q1 '26: 27.08 Q2 '26: 27.94 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.